Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of the investigational
drugs Avastin and Tarceva are effective in patients with mesothelioma who have previously
been treated with chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Massachusetts General Hospital University of Chicago